SRXN1

sulfiredoxin 1

Basic information

Region (hg38): 20:646615-653200

Previous symbols: [ "C20orf139" ]

Links

ENSG00000271303NCBI:140809OMIM:617583HGNC:16132Uniprot:Q9BYN0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SRXN1 gene.

  • not_specified (19 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRXN1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000080725.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
0
missense
19
clinvar
19
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 0 19 0 0
Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SRXN1protein_codingprotein_codingENST00000381962 26756
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.06970.752125585021255870.00000796
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2955460.50.8930.00000339823
Missense in Polyphen3028.6761.0462322
Synonymous0.3682729.50.9140.00000175301
Loss of Function0.93124.010.4992.57e-739

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000008810.00000881
Middle Eastern0.000.00
South Asian0.000.00
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Contributes to oxidative stress resistance by reducing cysteine-sulfinic acid formed under exposure to oxidants in the peroxiredoxins PRDX1, PRDX2, PRDX3 and PRDX4. Does not act on PRDX5 or PRDX6. May catalyze the reduction in a multi-step process by acting both as a specific phosphotransferase and a thioltransferase. {ECO:0000269|PubMed:15448164, ECO:0000269|PubMed:15590625}.;
Pathway
Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling (Consensus)

Haploinsufficiency Scores

pHI
0.103
hipred
Y
hipred_score
0.672
ghis

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.982

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Srxn1
Phenotype
homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; immune system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
response to oxidative stress;cellular response to oxidative stress;oxidation-reduction process;cellular oxidant detoxification
Cellular component
cytosol
Molecular function
protein binding;ATP binding;oxidoreductase activity, acting on a sulfur group of donors;sulfiredoxin activity